Severe hypokalemia, rhabdomyolysis, muscle paralysis, and respiratory impairment in a hypertensive patient taking herbal medicines containing licorice

Internal Medicine

Volumn 46, Issue 9, 2007, Pages 575-578

  Yasue, Hirofumi ^a   Itoh, Teruhiko ^a   Mizuno, Yuji ^a   Harada, Eisaku ^a  

^a Kumamoto Kinoh Hospital   (Japan)

Author keywords

11 hydroxysteroid dehydrogenase; Hypokalemia; Licorice; Pseudoaldosteronism; Rhabdomyolysis

Indexed keywords

AMLODIPINE; ANTIBIOTIC AGENT; ASPARTATE POTASSIUM; C REACTIVE PROTEIN; CREATINE KINASE; DEXAMETHASONE; GLYCYRRHIZA EXTRACT; HERBACEOUS AGENT; MYOGLOBIN; NONSTEROID ANTIINFLAMMATORY AGENT; POTASSIUM; POTASSIUM CHLORIDE; POTASSIUM DERIVATIVE; SPIRONOLACTONE; UNCLASSIFIED DRUG; MINERALOCORTICOID RECEPTOR;

ABNORMAL LABORATORY RESULT; AGED; ALDOSTERONE BLOOD LEVEL; AREFLEXIA; ARTICLE; ASPIRATION; CASE REPORT; CREATINE KINASE BLOOD LEVEL; DRUG WITHDRAWAL; ECG ABNORMALITY; FEMALE; FLACCID PARALYSIS; GLYCYRRHIZA; HUMAN; HYPERTENSION; HYPOKALEMIA; KNEE PAIN; PARALYSIS; PLASMA RENIN ACTIVITY; POTASSIUM BLOOD LEVEL; POTASSIUM TRANSPORT; PROTEIN BLOOD LEVEL; PSEUDOGOUT; RESPIRATORY TRACT DISEASE; RHABDOMYOLYSIS; TRANSFUSION; BLOOD; BREATHING DISORDER; DRUG ANTAGONISM; HOSPITALIZATION; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PHYTOTHERAPY; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; AGED, 80 AND OVER; FEMALE; GLYCYRRHIZA; HUMANS; HYPERTENSION; HYPOKALEMIA; INJECTIONS, INTRAVENOUS; PARALYSIS; PHYTOTHERAPY; POTASSIUM; RECEPTORS, MINERALOCORTICOID; RESPIRATION DISORDERS; RHABDOMYOLYSIS; SEVERITY OF ILLNESS INDEX; SPIRONOLACTONE; TREATMENT OUTCOME;

EID: 34249710193     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.46.6316     Document Type: Article

References (17)

1. The Japan Society for Oriental Medicine. Precautionary instruction. In Introduction to KAMPO. Elsevier, Tokyo, 2005: 90-91.
2. Farese RV Jr, Biglieri EG, Shackleton CH, Irony I. Gomez Fontes R: Licorice-induced hypermineralocorticoidism. N Engl J Med 325: 1223-1227, 1991.
3. Kageyama Y, Suzuki H, Saruta T. Glycyrrhizin-induces mineralo-corticoid. activity through alterations in cortisol metabolism in the human kidney. J Endocrinol 135: 147-152, 1992.
4. Singer GG, Brenner BM. Fluid and electrolyte disturbances. In: Harrison's Principles of Internal Medicine. 16th ed. Kasper DL, Fauci AS, Longo DL, Braunwald B, Hauser SL, Jameson JL Eds. McGraw-Hill, New York, 2005: 258-263.
5. Conn JW, Rovner DR, Cohen EL. Licorice-induced pseudoal-dosteronism. Hypertension, hypokalemia, aldosteronopenia, and suppressed plasma renin activity. JAMA 205: 492-496, 1968.
6. White PC, Mune T, Agarwal AK. 11 beta-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess. Endocr Rev 18: 135-156, 1997.
7. Draper N, Stewart PM. 11beta-hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action. J Endocrinol 186: 251-271, 2005.
8. Armanini D, Fiore C, Mattarello MJ, Bielenberg J, Palermo M. History of the endocrine effects of licorice. Exp Clin Endocrinol Diabetes 110: 257-261, 2002.
9. Turnbull AV, Rivier CL. Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action. Physiol Rev 79: 1-71, 1999.
10. Arzt E. The gp130 cytokine family signaling in the pituitary gland: a paradigm for cytokine-neuroendocrine pathways. J Clin Invest 108: 1729-1733, 2001.
11. Chesnokova V, Melmed S. Minireview: neuro-immuno-endocrine modulation of the HPA axis by gp130 signaling molecules. Endocrinology 143: 1571-1574, 2002.
12. Zacharowski K, Zacharowski PA, Koch A, et al. Toll-like receptor 4 plays a crucial role in the immune-adrenal response to systemic inflammatory response syndrome. Proc Natl Acad Sci U S A 103: 6392-6397, 2006.
13. Cooper MS, Bujalska I, Rabbitt E, et al. Modulation of 11beta-hydroxysteroid dehydrogenase isozymes by proinflammatory cytokines in osteoblasts: an autocrine switch from glucocorticoid in-activation to activation. J Bone Miner Res 16: 1037-1044, 2001.
14. + and cAMP pathways. Am J Physiol Endocrinol Metab 290: E282-288, 2006.
15. Ferrari P, Sansonnens A, Dick B, Frey FJ. In vivo 11beta-HSD-2 activity: variability, salt-sensitivity, and effect of licorice. Hypertension 38: 1330-1336, 2001.
16. Sigurjonsdottir HA, Manhem K, Axelson M, Wallerstedt S. Subjects with essential hypertension are more sensitive to the inhibition of 11 beta-HSD by liquorice. J Hum Hypertens 17: 125-1233, 2003.
17. Homma M, Ishihara M, Qian W, Kohda Y. Effects of long term administration of Shakuyaku-kanzo-To and Shosaiko-To on serum potassium levels. Yakugaku Zasshi 126: 973-978, 2006 (in Japanese, Abstract in English).